The Community Cardiology Service (formerly the Heart Support Service) team has successfully negotiated a Joint Working Partnership between the Trust, Wirral Clinical Commissioning Group and pharmaceutical company Novartis to bring in nearly £750,000 over the next two years to pump prime the Trust’s heart failure care transformation project.
The aim is to reduce unplanned hospital admissions and improve clinical outcomes by providing heart patients with IV diuretics in the community and up skilling GPs and practice nurses in the management of heart failure and co-morbidities. It’s hoped that the scheme will eventually save the NHS around half a million pounds a year. The service is aiming to launch the project in the autumn, with a phased introduction of the new patient pathway beginning in November.
Nicola Williams, Community Cardiology Service Lead, has been working on the proposal with Novartis for the past 18 months and would be happy to talk to anyone who would like further information. It’s a fantastic example of what transformation really can achieve if you think big enough.